藥物/器械組合的全球市場

全球藥物器材組合市場規模預計將從 2024 年的1,294 億美元增至 2029 年底的 1,998 億美元，預測期內複合年成長率為 9.1%。

藥物/生物製藥/器材組合產品領域預計將從2024年的864億美元成長到2029年底的1,365億美元，複合年成長率為9.6%。此外，藥物/生物製藥組合產品領域預計將從 2024 年的 304 億美元成長到 2029年終的460 億美元，複合年成長率為 8.6%。

該報告調查了全球藥物/器材組合市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測，以及各個細分市場和地區的詳細資訊。格局、主要企業簡介等。

目錄

第1章執行摘要

• 市場展望
• 調查範圍
• 市場概況

第2章 市場概況

• 市場分析
• 監管狀況
• 專利審查
• 產品召回
• 產品平臺

第3章市場動態

• 市場動態：簡介
• 促進因素
• 抑制因素
• 任務
• 機會
• 專注於無機策略的主要企業

第4章市場區隔分析

• 細分細分
• 藥物/器械組合市場：依產品類型
• 藥物/生物製劑/器材組合產品
• 藥物/生物製劑/器材組合產品
• 藥物/器械/生物製藥組合產品
• 藥物/器械組合市場：依應用分類
• 心血管疾病
• 代謝紊亂
• 呼吸系統疾病
• 創傷護理
• 瘤
• 整形外科疾病
• 其他
• 地域分佈
• 藥物/器材組合市場：按地區
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第5章 新趨勢與新技術

• 概述
• 藥品與醫療設備結合的人工智慧
• 奈米科技
• 計算模型和模擬
• 人體器官晶片：徹底改變醫學研究
• 植入式藥物傳輸系統
• 無線植入
• 用於3D列印的智慧型藥物傳輸裝置
• 最近核准並推出的新藥物/器材組合產品

第6章 ESG發展

• 藥物/器械組合市場的 ESG永續性
• ESG風險評估
• 世衛組織指南和全球努力
• BCC的意見

第7章 競爭格局

• 企業市場占有率分析
• 併購/合作
• 策略聯盟

第8章附錄

• 調查方法
• 來源
• 簡稱
• 公司簡介
• 3M
• ABBOTT
• B. BRAUN SE
• BD
• BOSTON SCIENTIFIC CORP.
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• SMITH+NEPHEW
• STRYKER
• TERUMO CORP.

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

The drug/biologic-device combination products market is expected to grow from $86.4 billion in 2024 and is projected to reach $136.5 billion by the end of 2029, at a CAGR of 9.6% during the forecast period of 2024 to 2029.

The drug-biologic combination products market is expected to grow from $30.4 billion in 2024 and is projected to reach $46.0 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

Report Scope:

The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations' current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Report Includes:

• 40 data tables and 43 additional tables
• Overview of the global markets for drug-device combination (DDC) products and biological devices
• Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
• Review of the industry supply chain, using the Porter's Five Forces model, to analyze the micro- and macro environmental factors prevailing in the marketplace
• Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
• An analysis of the industry structure, including companies' market shares, alliances, M&A activity and venture funding outlook
• Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Insights
• Regulatory Landscape
• Patent Review
• Product Recalls
• Product Pipeline

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Drivers
• Wide Range of Potential Applications of Combinations Products
• Growing Prevalence of Chronic Diseases
• Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
• Restraints
• Device Reliability and Robustness
• Human Factors Testing
• Drug and Device Integration
• Accommodating Different Volumes
• Challenges
• Biological Safety Challenges in Drug-Device Combinations
• Regulatory Challenges
• Opportunities
• Technology advancements and Innovative Product Launches
• Continuous Growth
• Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Drug-Device Combinations Market by Product Type
• Drug/Biologic-Device Combination Products
• Drug-Biologic Drug-Device Combination Products
• Drug, Device and Biologic Combination Products
• Drug-Device Combinations Market by Application
• Cardiovascular Diseases
• Metabolic Disorders
• Respiratory Diseases
• Wound Care
• Oncology
• Orthopedic Conditions
• Others
• Geographic Breakdown
• Drug-Device Combinations Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Trends and Technologies

• Overview
• AI in Drug-Device Combination
• Nanotechnology
• Computational Models and Simulation
• Human Organs-on-Chips: Revolutionizing Medical Research
• Implantable Drug Delivery Systems
• Wireless Implants
• Smart Drug Delivery Devices for 3D Printing
• Recent Approvals and Launch of Novel Drug-device Combination Products

Chapter 6 ESG Development

• Introduction
• ESG Sustainability in Drug-Device Combinations Market
• ESG Risk Ratings
• WHO Guidelines and Global Initiatives
• BCC Research Viewpoint

Chapter 7 Competitive Landscape

• Company Share Analysis
• Mergers, Acquisitions and Collaborations
• Strategic Alliances

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 3M
• ABBOTT
• B. BRAUN SE
• BD
• BOSTON SCIENTIFIC CORP.
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• SMITH+NEPHEW
• STRYKER
• TERUMO CORP.

List of Tables

• Summary Table : Global Market for Drug-Device Combinations, by Product Type, Through 2029
• Table 1 : EU Combination Product Regulation
• Table 2 : Granted Patents on Drug-Device Combination Products in 2024, U.S.
• Table 3 : Recalled Drug-Device Combination Products, 2021-2024
• Table 4 : Drug-Device Combination Product Pipeline
• Table 5 : Projected Number of Adults 50 Years and Older With >=1 Chronic Condition in the United States, 2020-2050
• Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2029
• Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029
• Table 8 : Global Market for Drug Eluting Stents (DES), by Region, Through 2029
• Table 9 : Marketed or Late-stage Development Products in DCDs
• Table 10 : Global Market for Prefilled Syringe (PFS), by Region, Through 2029
• Table 11 : Global Market for Inhalers, by Region, Through 2029
• Table 12 : Global Market for Nebulizers, by Region, Through 2029
• Table 13 : Global Market for Wound Care Products, by Region, Through 2029
• Table 14 : Global Market for Implants, by Region, Through 2029
• Table 15 : Available Catheter Types in Clinical Use, 2022
• Table 16 : Global Market for Antimicrobial Catheters, by Region, Through 2029
• Table 17 : Global Market for Transdermal Patches, by Region, Through 2029
• Table 18 : Global Market for Photodynamic Therapy (PDT), by Region, Through 2029
• Table 19 : Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029
• Table 20 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029
• Table 21 : FDA Approved ADCs
• Table 22 : Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029
• Table 23 : Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029
• Table 24 : Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029
• Table 25 : Global Market for Drug-Device Combination Products, by Application, Through 2029
• Table 26 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029
• Table 27 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029
• Table 28 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029
• Table 29 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029
• Table 30 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029
• Table 31 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029
• Table 32 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029
• Table 33 : Global Market for Drug-Device Combination Products, by Region, Through 2029
• Table 34 : North American Market for Drug-Device Combination Products, by Country, Through 2029
• Table 35 : European Market for Drug-Device Combination Products, by Country, Through 2029
• Table 36 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029
• Table 37 : ESG Highlights, by Major Players, 2023
• Table 38 : ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023
• Table 39 : Market Players and the Products They Offer for Various Applications
• Table 40 : Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021-2024
• Table 41 : Major Strategic Alliances in the Drug-Device Combination Industry, 2021-2024
• Table 42 : Information Sources in this Report
• Table 43 : Major Abbreviations Used in This Report
• Table 44 : 3M: Company Snapshot
• Table 45 : 3M: Financial Performance, FY 2022 and 2023
• Table 46 : 3M: Products Portfolio
• Table 47 : 3M: News/Key Developments, 2023
• Table 48 : Abbott: Company Snapshot
• Table 49 : Abbott: Financial Performance, FY 2022 and 2023
• Table 50 : Abbott: Products Portfolio
• Table 51 : Abbott: News/Key Developments, 2024
• Table 52 : B Braun SE: Company Snapshot
• Table 53 : B Braun SE: Financial Performance, FY 2022 and 2023
• Table 54 : B. Braun SE: Products Portfolio
• Table 55 : B. Braun SE: News/Key Developments, 2022
• Table 56 : BD: Company Snapshot
• Table 57 : BD: Financial Performance, FY 2022 and 2023
• Table 58 : BD: Product Portfolio
• Table 59 : BD: News/Key Developments, 2023
• Table 60 : Boston Scientific Corp.: Company Snapshot
• Table 61 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
• Table 62 : Boston Scientific Corp.: Products Portfolio
• Table 63 : Boston Scientific Corp.: News/Key Developments, 2024
• Table 64 : Johnson & Johnson Services Inc.: Company Snapshot
• Table 65 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
• Table 66 : Johnson & Johnson Services Inc.: Product Portfolio
• Table 67 : Johnson & Johnson Services Inc.: News/Key Developments, 2022
• Table 68 : Medtronic: Company Snapshot
• Table 69 : Medtronic: Financial Performance, FY 2022 and 2023
• Table 70 : Medtronic: Products Portfolio
• Table 71 : Medtronic: News/Key Developments, 2024
• Table 72 : Smith+Nephew: Company Snapshot
• Table 73 : Smith+Nephew: Financial Performance, FY 2022 and 2023
• Table 74 : Smith+Nephew: Products Portfolio
• Table 75 : Smith+Nephew: News/Key Developments, 2024
• Table 76 : Stryker: Company Snapshot
• Table 77 : Stryker: Financial Performance, FY 2022 and 2023
• Table 78 : Stryker: Products Portfolio
• Table 79 : Terumo Corp.: Company Snapshot
• Table 80 : Terumo Corp.: Financial Performance, FY 2022 and 2023
• Table 81 : Terumo Corp.: Product Portfolio
• Table 82 : Terumo Corp.: News/Key Developments, 2023

List of Figures

• Summary Figure : Global Market for Drug-Device Combinations, by Product Type, 2021-2029
• Figure 1 : U.S. FDA Combination Product Approval Pathway
• Figure 2 : Snapshot of the Global Markets for Drug-Device Combinations
• Figure 3 : Share of New Cancer Cases (Incidence) Globally, by Region, 2022
• Figure 4 : Share of Cancer Mortality Cases Globally, by Region, 2022
• Figure 5 : Global Market Shares of Drug-Device Combination Products, by Product Type, 2023
• Figure 6 : Global Market for Drug-Device Combination Products, by Region, 2021-2029
• Figure 7 : Global Market Shares of Drug-Device Combination Products, by Region, 2023
• Figure 8 : Traditional and New Generation Drug-Device Combination
• Figure 9 : Global Market Shares of Drug-Device Combination Products, by Company, 2023
• Figure 10 : 3M: Revenue Share, by Country/Region, FY 2023
• Figure 11 : 3M: Revenue Share, by Business Unit, FY 2023
• Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
• Figure 13 : Abbott: Revenue Share, by Business Unit, FY 2023
• Figure 14 : B Braun SE: Revenue Share, by Country/Region, FY 2023
• Figure 15 : B Braun SE: Revenue Share, by Business Unit, FY 2023
• Figure 16 : BD: Revenue Share, by Country/Region, FY 2023
• Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
• Figure 18 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 19 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 20 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 21 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 22 : Medtronic: Revenue Share, by Country/Region, FY 2023
• Figure 23 : Medtronic: Revenue Share, by Business Unit, FY 2023
• Figure 24 : Smith+Nephew: Revenue Share, by Country/Region, FY 2023
• Figure 25 : Smith+Nephew: Revenue Share, by Business Unit, FY 2023
• Figure 26 : Stryker: Revenue Share, by Country/Region, FY 2023
• Figure 27 : Stryker: Revenue Share, by Business Unit, FY 2023
• Figure 28 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 29 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023